Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
Clinical trial NCT00772980 · COMPLETED
Trial details
- NCT number
- NCT00772980
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-06-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.